Guardant Health and Vall d'Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in EuropeBusiness Wire • 01/18/21
Guardant Health to Present Data at ASCO Gastrointestinal Cancers Symposium Showing Value of Liquid Biopsy to Advance Precision Oncology in Early to Late-Stage Colorectal CancerBusiness Wire • 01/14/21
Guardant Health to Participate in the 39th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 12/30/20
Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World Platform in Metastatic Breast CancerBusiness Wire • 12/07/20
Guardant Health, Inc. (GH) CEO Helmy Eltoukhy on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/06/20
Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020Business Wire • 10/16/20
Guardant Health Announces Closing of Public Offering of Common Stock, Including Option to Purchase Additional Shares by Selling StockholderBusiness Wire • 10/15/20
Guardant Health Announces Pricing of Public Offering of Common Stock by Selling StockholderBusiness Wire • 10/07/20